DexCom (DXCM) Tops Q2 EPS by 31c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $69.07 -4.69%
Revenue Growth %: +11.2%
Financial Fact:
Total revenue: 148.6M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +11.2%
Financial Fact:
Total revenue: 148.6M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.76, $0.31 better than the analyst estimate of $0.45. Revenue for the quarter came in at $59.5 million versus the consensus estimate of $551.27 million.
GUIDANCE:
DexCom sees FY2021 revenue of $2.35-2.4 billion, versus the consensus of $2.34 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
- Sun Communities names Ileana McAlary as general counsel and EVP
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
